09 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/09/3058345/0/en/Cingulate-Receives-3-Million-Grant-from-Private-Foundation-to-Accelerate-Development-of-Anxiety-Asset-CTx-2103-buspirone.html
01 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/01/2789332/0/en/Cingulate-Receives-Guidance-from-FDA-on-Path-Forward-for-Anxiety-Asset-CTx-2103-buspirone.html